Matinas BioPharma Holdings (MTNB) Depreciation and Depletion (2013 - 2021)
Matinas BioPharma Holdings (MTNB) reported Depreciation and Depletion of -$175000.0 for Q4 2021, down 401.2% year-over-year from $58100.0 in Q4 2020, and down 382.26% quarter-over-quarter from $62000.0 in Q3 2021.
Matinas BioPharma Holdings (MTNB) Depreciation and Depletion (2013 - 2021) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 7 years of Depreciation and Depletion data on file, last reported at -$175000.0 in Q4 2021.
- Depreciation and Depletion for Q4 2021 came in at -$175000.0, down 401.2% year-over-year; the trailing twelve-month figure through Dec 2021 was $5000.0 (down 97.85% YoY), and the FY2025 annual result was $2.1 million, changed N/A from the prior year.
- Depreciation and Depletion slipped to -$175000.0 in Q4 2021 per MTNB's latest filing, from $62000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $62000.0 in Q3 2021 and troughed at -$175000.0 in Q4 2021.
- A 3-year average of $35827.3 and a median of $58000.0 in 2020 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2020 and 2021: Depreciation and Depletion rose 21.09% in 2020, then sank 401.2% in 2021.
- A 3-year view of Depreciation and Depletion shows it stood at $57100.0 in 2019, then grew by 1.75% to $58100.0 in 2020, then slumped by 401.2% to -$175000.0 in 2021.
- Business Quant data shows MTNB's Depreciation and Depletion at -$175000.0 in Q4 2021, $62000.0 in Q3 2021, and $59000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -175,000.00 |
| Dec 31, 2021 | -175,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | 59,000.00 |
| Jun 30, 2021 | 59,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 58,100.00 |
| Dec 31, 2020 | 58,100.00 |
| Sep 30, 2020 | 58,000.00 |
| Sep 30, 2020 | 58,000.00 |
| Jun 30, 2020 | 58,000.00 |
| Jun 30, 2020 | 58,000.00 |
| Mar 31, 2020 | 58,000.00 |
| Mar 31, 2020 | 58,000.00 |
| Dec 31, 2019 | 57,100.00 |
| Dec 31, 2019 | 57,100.00 |
| Sep 30, 2019 | 52,000.00 |
| Sep 30, 2019 | 52,000.00 |